RIPE-KG · Version 1.1.0 · Resource
ripekg:publication-details/RIPEA5A5547915735AD6D
https://w3id.org/ripe/ripe-kg/publication-details/RIPEA5A5547915735AD6D
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA5A5547915735AD6D |
prov:used |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
prism:eIssn |
2072-6643 |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
prism:publicationDate |
2025-04-02 |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
prism:publicationName |
Nutrients |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
dcterms:publisher |
ripekg:publisher/RIPEP526B502CAF55D720MDPI AG |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
dcterms:title |
Effects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
rdf:type |
http://purl.org/spar/fabio/BibliographicMetadata |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
rdf:type |
rdfs:Resource |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
rdf:type |
owl:Thing |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
rdf:type |
ripe:PublicationDetailsPublication details |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
rdf:type |
tido:Evidence |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA5A5547915735AD6D |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA5A5547915735AD6D |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
ripe:concerns |
ripekg:work/10.3390%2Fnu17071246Effects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
ripekg:publication-details/RIPEA5A5547915735AD6DEffects of Vitamin D3 Treatment on Polycystic Ovary Symptoms: A Prospective Double-Blind Two-Phase Randomized Controlled Clinical Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA5A5547915735AD6D-inspectai-1-1 |